Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kyung-Hun Lee

Showing results (101-110 of 248) with videos related to

Pageof 25
Sort By:
European Journal of Nuclear Medicine and Molecular Imaging|November 5, 2017
Integrated <sup>18</sup>F-FDG PET/MRI in breast cancer: early prediction of response to neoadjuvant chemotherapyNariya Cho, Seock-Ah Im, Gi Jeong Cheon, et al.
Cancer Letters|August 24, 2010
RAD001 shows activity against gastric cancer cells and overcomes 5-FU resistance by downregulating thymidylate synthaseKyung-Hun Lee, Hyung-Seok Hur, Seock-Ah Im, et al.
Oncotarget|October 27, 2016
Soluble programmed death-ligand 1 (sPDL1) and neutrophil-to-lymphocyte ratio (NLR) predicts survival in advanced biliary tract cancer patients treated with palliative chemotherapyHyerim Ha, Ah-Rong Nam, Ju-Hee Bang, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|July 27, 2024
Risk of radionecrosis in HER2-positive breast cancer with brain metastasis receiving trastuzumab emtansine (T-DM1) and brain stereotactic radiosurgerySeok-Joo Chun, Kyubo Kim, Yong Bae Kim, et al.
Cancer Research and Treatment|January 22, 2016
Splenomegaly and Its Associations with Genetic Polymorphisms and Treatment Outcome in Colorectal Cancer Patients Treated with Adjuvant FOLFOXMi-Jung Kim, Sae-Won Han, Dae-Won Lee, et al.
Cancer Medicine|April 15, 2016
A phase I study of the human anti-activin receptor-like kinase 1 antibody PF-03446962 in Asian patients with advanced solid tumorsToshihiko Doi, Kyung-Hun Lee, Tae-Min Kim, et al.
The Lancet. Oncology|June 6, 2020
Atezolizumab with or without bevacizumab in unresectable hepatocellular carcinoma (GO30140): an open-label, multicentre, phase 1b studyMichael S Lee, Baek-Yeol Ryoo, Chih-Hung Hsu, et al.
Clinical Transplantation|April 12, 2007
Glutathione S-transferase A1 polymorphisms and acute graft-vs.-host disease in HLA-matched sibling allogeneic hematopoietic stem cell transplantationInho Kim, Bhumsuk Keam, Kyung-Hun Lee, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|August 12, 2020
The prognostic role of soluble transforming growth factor-β and its correlation with soluble programmed death-ligand 1 in biliary tract cancerJin Won Kim, Kyung-Hun Lee, Ji-Won Kim, et al.
Cancer Chemotherapy and Pharmacology|September 17, 2013
Serum epidermal growth factor is associated with prognosis and hormone receptor status in patients with HER2-positive metastatic breast cancer treated with first-line trastuzumab plus taxane chemotherapyJi-Won Kim, Jee Hyun Kim, Seock-Ah Im, et al.
Pageof 25

Showing results (101-110 of 248) with videos related to

Sort By:
Pageof 25
European Journal of Nuclear Medicine and Molecular Imaging|November 5, 2017
Integrated <sup>18</sup>F-FDG PET/MRI in breast cancer: early prediction of response to neoadjuvant chemotherapyNariya Cho, Seock-Ah Im, Gi Jeong Cheon, et al.
Cancer Letters|August 24, 2010
RAD001 shows activity against gastric cancer cells and overcomes 5-FU resistance by downregulating thymidylate synthaseKyung-Hun Lee, Hyung-Seok Hur, Seock-Ah Im, et al.
Oncotarget|October 27, 2016
Soluble programmed death-ligand 1 (sPDL1) and neutrophil-to-lymphocyte ratio (NLR) predicts survival in advanced biliary tract cancer patients treated with palliative chemotherapyHyerim Ha, Ah-Rong Nam, Ju-Hee Bang, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|July 27, 2024
Risk of radionecrosis in HER2-positive breast cancer with brain metastasis receiving trastuzumab emtansine (T-DM1) and brain stereotactic radiosurgerySeok-Joo Chun, Kyubo Kim, Yong Bae Kim, et al.
Cancer Research and Treatment|January 22, 2016
Splenomegaly and Its Associations with Genetic Polymorphisms and Treatment Outcome in Colorectal Cancer Patients Treated with Adjuvant FOLFOXMi-Jung Kim, Sae-Won Han, Dae-Won Lee, et al.
Cancer Medicine|April 15, 2016
A phase I study of the human anti-activin receptor-like kinase 1 antibody PF-03446962 in Asian patients with advanced solid tumorsToshihiko Doi, Kyung-Hun Lee, Tae-Min Kim, et al.
The Lancet. Oncology|June 6, 2020
Atezolizumab with or without bevacizumab in unresectable hepatocellular carcinoma (GO30140): an open-label, multicentre, phase 1b studyMichael S Lee, Baek-Yeol Ryoo, Chih-Hung Hsu, et al.
Clinical Transplantation|April 12, 2007
Glutathione S-transferase A1 polymorphisms and acute graft-vs.-host disease in HLA-matched sibling allogeneic hematopoietic stem cell transplantationInho Kim, Bhumsuk Keam, Kyung-Hun Lee, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|August 12, 2020
The prognostic role of soluble transforming growth factor-β and its correlation with soluble programmed death-ligand 1 in biliary tract cancerJin Won Kim, Kyung-Hun Lee, Ji-Won Kim, et al.
Cancer Chemotherapy and Pharmacology|September 17, 2013
Serum epidermal growth factor is associated with prognosis and hormone receptor status in patients with HER2-positive metastatic breast cancer treated with first-line trastuzumab plus taxane chemotherapyJi-Won Kim, Jee Hyun Kim, Seock-Ah Im, et al.
Pageof 25